^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Merkel Cell Carcinoma
    Drug:Yervoy (ipilimumab) (CTLA4 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/10/2023
    Excerpt:
    Merkel Cell Carcinoma...Useful in Certain Circumstances:...Ipilimumab ± nivolumab